Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00006383
Ignite Creation Date: 2024-05-05 @ 9:42 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006383
Protocol Section: NCT00006383
Start Identification Module Data
Expand Identification Module Data
Brief Title: Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkins Lymphoma
Official Title: Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Diffuse Large B-Cell Non-Hodgkins Lymphoma That is Refractory or Relapsed After Second-Line Combination Chemotherapy Revised Title Per 0301 SR Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Aggressive Non-Hodgkins Lymphoma That is Refractory to or Relapsed After Second-Line Combination Chemotherapy
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: CDR0000068259
Secondary IDs
Secondary ID Type Domain Link
UCLA-0002028 None None None
INEX-CA99002 None None None
Start Status Module Data
Status Verified Date: 2002-12
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Inex Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Inex Pharmaceuticals
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload